Insulin resistance of amino acid and protein metabolism in type 2 diabetes (Q37865137)

24 August 2017

1 reference

title

Insulin resistance of amino acid and protein metabolism in type 2 diabetes (English)

1 reference

24 August 2017

0 references

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21492974

30 November 2024

Paolo Tessari

1 reference

24 August 2017

Diego Cecchet

1 reference

24 August 2017

Alessandra Cosma

1 reference

24 August 2017

Lucia Puricelli

1 reference

24 August 2017

Renato Millioni

1 reference

24 August 2017

Monica Vedovato

1 reference

24 August 2017

Antonio Tiengo

1 reference

24 August 2017

language of work or name

1 reference

13 April 2011

1 reference

full work available at URL

24 August 2017

https://api.elsevier.com/content/article/PII:S0261561411000410?httpAccept=text/xml

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

https://api.elsevier.com/content/article/PII:S0261561411000410?httpAccept=text/plain

30 November 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

30 November 2024

1 reference

24 August 2017

1 reference

24 August 2017

1 reference

24 August 2017

page(s)

267-272

1 reference

Skeletal muscle insulin resistance is the primary defect in type 2 diabetes

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Functional pancreatic beta-cell mass: involvement in type 2 diabetes and therapeutic intervention

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Free fatty acids and pathogenesis of type 2 diabetes mellitus

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Effects of insulin on whole-body and regional amino acid metabolism.

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

The regulation of body and skeletal muscle protein metabolism by hormones and amino acids

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Protein and diabetes: much advice, little research

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Excessive loss of skeletal muscle mass in older adults with type 2 diabetes

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Comparison of body fat composition and serum adiponectin levels in diabetic obesity and non-diabetic obesity.

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS).

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Restoration of muscle mitochondrial function and metabolic flexibility in type 2 diabetes by exercise training is paralleled by increased myocellular fat storage and improved insulin sensitivity

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Diurnal variation in glucose and leucine metabolism in non-insulin-dependent diabetes

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Fasting and postmeal phenylalanine metabolism in mild type 2 diabetes

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Insulin acutely increases fibrinogen production in individuals with type 2 diabetes but not in individuals without diabetes

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Effects of insulin on methionine and homocysteine kinetics in type 2 diabetes with nephropathy

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Failure of glyburide and insulin treatment to decrease leucine flux in obese type II diabetic patients

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Synthesis rate of muscle proteins, muscle functions, and amino acid kinetics in type 2 diabetes

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Skeletal muscle proteolysis is reduced in noninsulin-dependent diabetes mellitus and is unaltered by euglycemic hyperinsulinemia or intensive insulin therapy

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Insulin resistance of protein metabolism in type 2 diabetes

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy.

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Differential effects of hyperinsulinemia and hyperaminoacidemia on leucine-carbon metabolism in vivo. Evidence for distinct mechanisms in regulation of net amino acid deposition

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. Role of substrate availability on estimates of whole body protein synthesis

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Insulin in the regulation of protein turnover in heart and skeletal muscle

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Hormonal regulation of protein degradation and synthesis in skeletal muscle

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

The muscle protein synthetic response to carbohydrate and protein ingestion is not impaired in men with longstanding type 2 diabetes

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Differential effects of insulin deprivation and systemic insulin treatment on plasma protein synthesis in type 1 diabetic people.

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Albumin and fibrinogen synthesis and insulin effect in type 2 diabetic patients with normoalbuminuria

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Diabetic nephropathy is associated with increased albumin and fibrinogen production in patients with type 2 diabetes

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Plasma protein synthesis in patients with low-grade nephrotic proteinuria

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Physiological mechanisms regulating the expression of endothelial-type NO synthase.

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Pathways and regulation of homocysteine metabolism in mammals

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Insulin in methionine and homocysteine kinetics in healthy humans: plasma vs. intracellular models

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

The L-arginine-nitric oxide pathway

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Insulin action and insulin resistance in vascular endothelium.

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Effect of hyperinsulinaemia on renal function and nitrate/nitrite excretion in healthy subjects

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

High concentration of glucose inhibits glomerular endothelial eNOS through a PKC mechanism

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Nitric oxide availability in diabetes mellitus.

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Decreased nitric oxide end-products and its relationship with high density lipoprotein and oxidative stress in people with type 2 diabetes without complications

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy.

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

L-arginine-nitric oxide kinetics in normal and type 2 diabetic subjects: a stable-labelled 15N arginine approach

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Workshop: endothelial cell dysfunction leading to diabetic nephropathy : focus on nitric oxide

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

Acute effect of insulin on nitric oxide synthesis in humans: a precursor-product isotopic study

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLNU.2011.02.009

30 November 2024

Identifiers

DOI

1 reference

24 August 2017

1 reference